Platinum resistance is more likely to develop in lung cancer brain metastases through a mechanism that reduces ferroptosis by upregulating glutathione peroxidase 4 (GPX4) expression and inhibiting GSH depletion via the Wnt/NRF2/GPX4 axis (27). The gene discussed is GPX4; the disease is lung carcinoma.